Figure 1 | Scientific Reports

Figure 1

From: Plasma androgen receptor and serum chromogranin A in advanced prostate cancer

Figure 1

Survival in patients treated with abiraterone or enzalutamide by AR status and CgA levels in the Primary cohort. PFS (A) and OS (B) in AR-normal and PFS (C) and OS (D) in AR-gained patients according to three different CgA level groups. The blue line is for patients with serum CgA <120 ng/mL, the orange line for CgA between 120 and 360 ng/mL, and the green line for CgA level >360 ng/mL.

Back to article page